{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:03:14Z","timestamp":1760295794404},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,4,23]],"date-time":"2015-04-23T00:00:00Z","timestamp":1429747200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s13063-015-0692-3","type":"journal-article","created":{"date-parts":[[2015,4,22]],"date-time":"2015-04-22T00:39:12Z","timestamp":1429663152000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Pulsed oral sirolimus in advanced autosomal-dominant polycystic kidney disease (Vienna RAP Study): study protocol for a randomized controlled trial"],"prefix":"10.1186","volume":"16","author":[{"given":"Markus","family":"Riegersperger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harald","family":"Herkner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gere","family":"Sunder-Plassmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,4,23]]},"reference":[{"key":"692_CR1","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/ki.2009.128","volume":"76","author":"VE Torres","year":"2009","unstructured":"Torres VE, Harris PC. Autosomal dominant polycystic kidney disease: the last 3\u00a0years. Kidney Int. 2009;76:149\u201368.","journal-title":"Kidney Int"},{"issue":"1","key":"692_CR2","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1681\/ASN.2008050507","volume":"20","author":"Y Pei","year":"2009","unstructured":"Pei Y, Obaji J, Dupuis A, Paterson AD, Magistroni R, Dicks E, et al. Unified criteria for ultrasonographic diagnosis of ADPKD. J Am Soc Nephrol. 2009;20(1):205\u201312.","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"692_CR3","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1681\/ASN.2007020155","volume":"18","author":"AB Chapman","year":"2007","unstructured":"Chapman AB. Autosomal dominant polycystic kidney disease: time for a change? J Am Soc Nephrol. 2007;18(5):1399\u2013407.","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"692_CR4","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1038\/ki.1992.195","volume":"41","author":"PA Gabow","year":"1992","unstructured":"Gabow PA, Johnson AM, Kaehny WD, Kimberling WJ, Lezotte DC, Duley IT, et al. Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease. Kidney Int. 1992;41(5):1311\u20139.","journal-title":"Kidney Int"},{"issue":"1","key":"692_CR5","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1681\/ASN.2004080660","volume":"16","author":"Y Tao","year":"2005","unstructured":"Tao Y, Kim J, Schrier RW, Edelstein CL. Rapamycin markedly slows disease progression in a rat model of polycystic kidney disease. J Am Soc Nephrol. 2005;16(1):46\u201351.","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"692_CR6","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1093\/ndt\/gfi181","volume":"21","author":"PR Wahl","year":"2006","unstructured":"Wahl PR, Serra AL, Le Hir M, Molle KD, Hall MN, W\u00fcthrich RP. Inhibition of mTOR with sirolimus slows disease progression in Han: SPRD rats with autosomal polycystic kidney disease (ADPKD). Nephrol Dial Transplant. 2006;21(3):598\u2013604.","journal-title":"Nephrol Dial Transplant"},{"issue":"9","key":"692_CR7","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1056\/NEJMoa0907419","volume":"363","author":"AL Serra","year":"2010","unstructured":"Serra AL, Poster D, Kistler AD, Krauer F, Raina S, Young J, et al. Sirolimus and kidney growth in autosomal dominant polycystic kidney disease. N Engl J Med. 2010;363(9):820\u20139.","journal-title":"N Engl J Med"},{"issue":"9","key":"692_CR8","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1056\/NEJMoa1003491","volume":"363","author":"G Walz","year":"2010","unstructured":"Walz G, Budde K, Mannaa MD, N\u00fcrnberger J, Wanner C, Sommerer C, et al. Everolimus in patients with autosomal dominant polycystic kidney disease. N Engl J Med. 2010;363(9):830\u201340.","journal-title":"N Engl J Med"},{"issue":"1","key":"692_CR9","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1097\/01.tp.0000225772.22757.5e","volume":"82","author":"W Lieberthal","year":"2006","unstructured":"Lieberthal W, Fuhro R, Andry C, Patel V, Levine JS. Rapamycin delays but does not prevent recovery from acute renal failure: role of acquired tubular resistance. Transplantation. 2006;82(1):17\u201322.","journal-title":"Transplantation"},{"issue":"6","key":"692_CR10","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1053\/j.seminoncol.2009.10.009","volume":"36","author":"JP Boni","year":"2009","unstructured":"Boni JP, Hug B, Leister C, Sonnichsen D. Temsirolimus, a novel mTOR inhibitor: its clinical development for renal cell carcinoma and other tumors. Semin Oncol. 2009;36(6):18\u201325.","journal-title":"Semin Oncol"},{"issue":"6","key":"692_CR11","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1097\/HJH.0b013e3281fc975a","volume":"25","author":"G Mancia","year":"2007","unstructured":"Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007;25(6):1105\u201387.","journal-title":"J Hypertens"},{"key":"692_CR12","first-page":"S1","volume":"113","author":"SM Moe","year":"2009","unstructured":"Moe SM, Dr\u00fceke TB, Block GA, Cannata-And\u00eda JB, Elder GJ, Fukagawa M, et al. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease - mineral and bone disorder (CKD-MBD). Kidney Int Suppl. 2009;113:S1\u2013130.","journal-title":"Kidney Int Suppl"},{"issue":"6","key":"692_CR13","doi-asserted-by":"publisher","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","volume":"130","author":"AS Levey","year":"1999","unstructured":"Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130(6):461\u201370.","journal-title":"Ann Intern Med"},{"issue":"9","key":"692_CR14","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604\u201312.","journal-title":"Ann Intern Med"},{"issue":"1","key":"692_CR15","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/j.1523-1755.2005.00077.x","volume":"67","author":"TH Jafar","year":"2005","unstructured":"Jafar TH, Stark PC, Schmid CH, Strandgaard S, Kamper AL, Maschio G, et al. The effect of angiotensin-converting enzyme inhibitors on progression of advanced polycystic kidney disease. Kidney Int. 2005;67(1):265\u201371.","journal-title":"Kidney Int"},{"issue":"14","key":"692_CR16","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1056\/NEJMsr1203730","volume":"367","author":"RJ Little","year":"2012","unstructured":"Little RJ, D\u2019Agostino R, Cohen ML, Dickersin K, Emerson SS, Farrar JT, et al. The prevention and treatment of missing data in clinical trials. N Engl J Med. 2012;367(14):1355\u201360.","journal-title":"N Engl J Med"},{"issue":"7","key":"692_CR17","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1056\/NEJMoa1000552","volume":"363","author":"BA Cooper","year":"2010","unstructured":"Cooper BA, Branley P, Bulfone L, Collins JF, Craig JC, Fraenkel MB, et al. A randomized, controlled trial of early versus late initiation of dialysis. N Engl J Med. 2010;363(7):609\u201319.","journal-title":"N Engl J Med"},{"issue":"2","key":"692_CR18","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/ki.2008.558","volume":"75","author":"AD Kistler","year":"2009","unstructured":"Kistler AD, Poster D, Krauer F, Weishaupt D, Raina S, Senn O, et al. Increases in kidney volume in autosomal dominant polycystic kidney disease can be detected within 6\u00a0months. Kidney Int. 2009;75(2):235\u201341.","journal-title":"Kidney Int"},{"issue":"1","key":"692_CR19","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/sj.ki.5002624","volume":"73","author":"JJ Grantham","year":"2008","unstructured":"Grantham JJ, Cook LT, Torres VE, Bost JE, Chapman AB, Harris PC, et al. Determinants of renal volume in autosomal-dominant polycystic kidney disease. Kidney Int. 2008;73(1):108\u201316.","journal-title":"Kidney Int"},{"issue":"7","key":"692_CR20","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.2215\/CJN.00900112","volume":"7","author":"JJ Grantham","year":"2012","unstructured":"Grantham JJ, Mulamalla S, Grantham CJ, Wallace DP, Cook LT, Wetzel LH, et al. Detected renal cysts are tips of the iceberg in adults with ADPKD. Clin J Am Soc Nephrol. 2012;7(7):1087\u201393.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"692_CR21","doi-asserted-by":"publisher","first-page":"881","DOI":"10.2215\/CJN.02650313","volume":"9","author":"WE Braun","year":"2014","unstructured":"Braun WE, Schold JD, Stephany BR, Spirko RA, Herts BR. Low-dose rapamycin (sirolimus) effects in autosomal dominant polycystic kidney disease: an open-label randomized controlled pilot study. Clin J Am Soc Nephrol. 2014;9(5):881\u20138.","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-015-0692-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13063-015-0692-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-015-0692-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-015-0692-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T22:51:52Z","timestamp":1553640712000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-015-0692-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,23]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["692"],"URL":"https:\/\/doi.org\/10.1186\/s13063-015-0692-3","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,23]]},"assertion":[{"value":"8 August 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"182"}}